Peripheral tissues, including intercostal muscle, diaphragm and pancreas of SMA patients treated with onasemnogene also showed abnormal high expression of SMN transcripts, raising concerns similar to those noted with liver (Thomsen et al., 2021). Here, SMN1 is linked to proximal spinal muscular atrophy.